Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: The action for health in diabetes

Diabetes Care

Volumn 37, Issue 9, 2014, Pages 2548-2556

  Espeland, Mark A ^a   Glick, Henry A ^b   Bertoni, Alain ^a   Brancati, Frederick L ^c   Bray, George A ^d   Clark, Jeanne M ^c   Curtis, Jeffrey M ^e,f   Egan, Caitlin ^g   Evans, Mary ^e   Foreyt, John P ^h   Ghazarian, Siran ⁱ   Gregg, Edward W ^j   Hazuda, Helen P ^k   Hill, James O ^l   Hire, Don ^a   Horton, Edward S ^m   Hubbard, Van S ^e   Jakicic, John M ⁿ   Jeffery, Robert W ^o   Johnson, Karen C ^p   Kahn, Steven E ^q   Killean, Tina ^e,f   Kitabchi, Abbas E ^p   Knowler, William C ^e,f   Kriska, Andrea ⁿ   Lewis, Cora E ^r   Miller, Marsha ^l   Montez, Maria G ^k   Murillo, Anne ^q   Nathan, David M ^s   Nyenwe, Ebenezer ^p   Patricio, Jennifer ^t   Peters, Anne L ⁱ   Pi Sunyer, Xavier ^t   Pownall, Henry ^h   Redmon, J Bruce ^o   Rushing, Julia ^a   Ryan, Donna H ^d   Safford, Monika ^r   Tsai, Adam G ^l   Wadden, Thomas A ^b   Wing, Rena R ^g   Yanovski, Susan Z ^e   Zhang, Ping ^j   more..

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^f Southwest American Indian Center National Institute of Diabetes and Digestive and Kidney Diseases   (United States)

^g BROWN UNIVERSITY   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ Roybal Comprehensive Health Center   (United States)

^j CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^k UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^l UNIVERSITY OF COLORADO   (United States)

^m JOSLIN DIABETES CENTER   (United States)

ⁿ UNIVERSITY OF PITTSBURGH   (United States)

^o UNIVERSITY OF MINNESOTA   (United States)

^p UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^q UNIVERSITY OF WASHINGTON   (United States)

^r UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^s MASSACHUSETTS GENERAL HOSPITAL   (United States)

^t ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; GENERIC DRUG; NEUROLEPTIC AGENT; TETRAHYDROLIPSTATIN;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; COST CONTROL; DIABETES SUPPORT EDUCATION; DIAGNOSTIC PROCEDURE; DRUG COST; ETHNICITY; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HEALTH INSURANCE; HEALTH PROMOTION; HOME CARE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOGLYCEMIA; INTENSIVE LIFESTYLE INTERVENTION; INTENTION TO TREAT ANALYSIS; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL SERVICE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; REHABILITATION CARE; SEX; TELECONSULTATION; TRAINING; TREATMENT DURATION; WEIGHT REDUCTION; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; ECONOMICS; HEALTH SERVICE; LIFESTYLE; MIDDLE AGED; SINGLE BLIND PROCEDURE;

ADULT; AGED; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH SERVICES; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; SINGLE-BLIND METHOD;

EID: 84906706277     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0093     Document Type: Article

References (34)

1. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesityrelated health risk factors, 2001. JAMA 2003; 289:76-79
2. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of Obesity in the United States, 2009-2010. NCHS data brief no. 82. Hyattsville, MD, National Center for Health Statistics, 2012
3. Huang ES, O'Grady M, Basu A, Capretta JC. Projecting the future diabetes population size and related costs for the U.S. Diabetes Care 2009;32:2225-2229
4. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood) 2009;28:w822-w831
5. Tsai AG, Williamson DF, Glick HA. Direct medical cost of overweight and obesity in the USA: a quantitative systematic review. Obes Rev 2011;12:50-61
6. American Diabetes Association. Economic costs of diabetes in the US in 2007. Diabetes Care 2008;3:595-615
7. Liebl A, Breitscheidel L, Nicolay C, Happich M. Direct costs and health-related resource utilization in the 6 months after insulin initiation in German patients with type 2 diabetes mellitus in 2006: INSTIGATE study. Curr Med Res Opin 2008;24:2349-2358
8. Collins RW, Anderson JW. Medication cost savings associated with weight loss for obese non-insulin-dependent diabetic men and women. Prev Med 1995;24:369-374
9. Tsai AG, Glick HA, Shera D, Stern L, Samaha FF. Cost-effectiveness of a low-carbohydrate diet and a standard diet in severe obesity. Obes Res 2005;13:1834-1840
10. Herman WH, Hoerger TJ, Brandle M, et al; Diabetes Prevention Program Research Group. The cost-effectiveness of lifestyle modification or metformin in preventing type 2 diabetes in adults with impaired glucose tolerance. Ann Intern Med 2005;142:323-332
11. Wolf AM, Siadaty M, Yaeger B, et al. Effects of lifestyle intervention on health care costs: Improving Control with Activity and Nutrition (ICAN). J Am Diet Assoc 2007;107:1365-1373
12. Krukowski RA, Tilford JM, Harvey-Berino J, West DS. Comparing behavioral weight loss modalities: incremental cost-effectiveness of an internet-based versus an in-person condition. Obesity (Silver Spring) 2011;19:1629-1635
13. Diabetes Prevention Program Research Group. The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP/DPPOS. Diabetes Care 2012;35:723-730
14. Tsai AG, Wadden TA, Volger S, et al. Costeffectiveness of a primary care intervention to treat obesity. Int J Obes (Lond) 2013;37(Suppl. 1):S31-S37
15. Ryan DH, Espeland MA, Foster GD, et al; Look AHEAD Research Group. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003;24:610-628
16. Wing RR, Bolin P, Brancati FL, et al; Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013;369:145-154
17. Wadden TA, West DS, Delahanty L, et al; Look AHEAD Research Group. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it [published correction appears in Obesity (Silver Spring) 2007; 15:1339]. Obesity (Silver Spring) 2006;14: 737-752
18. Wesche-Thobaben JA. The development and description of the comparison group in the Look AHEAD trial. Clin Trials 2011;8:320-329
19. Healthcare Cost and Utilization Project. Overview of the Nationwide Inpatient Sample (NIS) Available from http://www.hcup-us.ahrq.gov/nisoverview. jsp. Accessed 15 September 2010
20. Levinson DR. Medicaid Drug Price Comparison: Average Sales Price to Average Wholesale Price. Publication OEI-03-05-00200. Washington, DC, Office of the Inspector General, Department of Health and Human Services, 2005
21. Levinson DR. Medicaid Drug Price Comparisons: Average Manufacturer Price to Published Prices. Publication OEI-05-05-00240. Washington, DC, Office of the Inspector General, Department of Health and Human Services, 2005
22. Wing RR; Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010;170:1566-1575
23. Jakicic JM, Jaramillo SA, Balasubramanyam A, et al; Look AHEAD Study Group. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD Study. Int J Obes (Lond) 2009;33:305-316
24. Foster GD, Borradaile KE, Sanders MH, et al; Sleep AHEAD Research Group of Look AHEAD Research Group. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med 2009;169: 1619-1626
25. Rubin RR, Peyrot M, Gaussoin SA, et al; Look AHEAD Research Group. Four-year analysis of cardiovascular disease risk factors, depression symptoms, and antidepressant medicine use in the Look AHEAD (Action for Health in Diabetes) clinical trial of weight loss in diabetes. Diabetes Care 2013;36: 1088-1094
26. Gregg E, Chen H, Wagenknecht L, et al.; Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012;308:2489-2496
27. Rejeski WJ, Ip EH, Bertoni AG, et al; Look AHEAD Research Group. Lifestyle change and mobility in obese adults with type 2 diabetes. N Engl J Med 2012;366:1209-1217
28. Greenway FL, Ryan DH, Bray GA, Rood JC, Tucker EW, Smith SR. Pharmaceutical cost savings of treating obesity with weight loss medications. Obes Res 1999;7:523-531
29. Potteiger CE, Paragi PR, Inverso NA, et al. Bariatric surgery: shedding the monetary weight of prescription costs in the managed care arena. Obes Surg 2004;14:725-730
30. Davis WA, Bruce DG, Davis TME. Economic impact of moderate weight loss in patients with type 2 diabetes: the Fremantle Diabetes Study. Diabet Med 2011;28:1131-1135
31. Redmon JB, Bertoni AG, Connelly S, et al; Look AHEAD Research Group. Effect of the look AHEAD study intervention on medication use and related cost to treat cardiovascular disease risk factors in individuals with type 2 diabetes. Diabetes Care 2010;33: 1153-1158
32. Köster I, von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germanydthe CoDiMstudy. Diabetologia 2006;49:1498-1504
33. Wolfenstetter SB. Future direct and indirect costs of obesity and the influence of gaining weight: results from the MONICA/KORA cohort studies, 1995-2005. Econ Hum Biol 2012;10: 127-138
34. Little RJA. Pattern-mixture models for multivariate incomplete data. J AmStat Assoc 1993; 87:1227-1237